Lareb notes newly reported deaths shortly after vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a total of 15 reports so far regarding deaths shortly after receiving the COVID-19 vaccinations.
New research in GGD test lanes on spread of coronavirus SARS-CoV-2 RIVM is launching a survey-based study this week on risk factors for the coronavirus SARS-CoV-2. The participants in this study are people who get tested for COVID-19 in a GGD test lane.
80 to 84-year-olds invited for vaccination sooner Starting tomorrow, the first people in the age group from 80-84 years in the Netherlands will receive an invitation from RIVM for a COVID-19 vaccination.
New variants disrupt plans In the past week, from 27 January to 2 February, 28,628 people in the Netherlands reportedly tested positive for COVID-19, a 20% decrease compared to the week of 20 to 26 January.
One person died shortly after COVID-19 vaccination The Pharmacovigilance Centre Lareb announced today that the centre had received a report of death shortly after receiving the Pfizer/BioNTech COVID-19 vaccination in the Netherlands.
Nationwide assessment of SARS-CoV-2 laboratories: very high quality The vast majority of the laboratories analysing COVID-19 tests are performing at the very highest standard of quality.
Long-term disruption of day/night rhythms increases risk of breast cancer and leads to gain in bodyweight Long-term disruption of day/night rhythms leads to an increase in breast cancer risk and bodyweight in mice susceptible to breast cancer.
High number of tick bites expected this summer It is expected that over the coming month, around half a million people will be bitten by a tick. Last month, considerably more tick bites have been reported compared to previous years.
Gardner Middlebrook Award 2015 to Dick van Soolingen RIVM congratulates Professor Dick van Soolingen, who was presented the highly coveted Gardner Middlebrook Award.
Annual report RIVM 2014 online In our annual report, we look back at compelling RIVM projects and research in 2014.